There is a paper by Song et al in Antiviral Research 76(2):178-85, 2007 Nov. Title is "Biological evaluation of anti-influenza viral activity of semi-synthetic catechin."
After detailing the nature of the experiments, the abstract concludes with: "The broad spectrum activity against various subtypes of influenza viruses may complement the limitations of current antivirals and contribute for managing potentially emerging influenza pandemic. The structure-activity data of catechin derivatives may usefully guideline future research endeavors for applying green tea catechins as alternative anti-viral agents."
Is this a straw in the wind? The text mentions that catechins work antivirally in a different manner from zanamivir (Relenza) and oseltamivir (Tamiflu).
- Forums
- ASX - By Stock
- BTA
- catechins as influenza antivirals
catechins as influenza antivirals
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online